Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) Director Nancy Ryan Gray sold 934 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $83.20, for a total value of $77,708.80. Following the completion of the transaction, the director now owns 5,633 shares in […]
Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company provided earnings per share guidance of 4.250-4.750 for the period, compared to the consensus earnings per share estimate of 4.270. The company issued revenue guidance of $130.0 million-$142.0 million, compared to the consensus revenue estimate of $138.5 million. […]
Ligand Pharmaceuticals (NASDAQ:LGND) Updates FY 2024 Earnings Guidance themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) updated its FY23 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $5.10-5.25 for the period, compared to the consensus estimate of $4.97. The company issued revenue guidance of $124-126 million, compared to the consensus revenue estimate of $127.17 million. Wall Street Analyst Weigh […]
Ligand Pharmaceuticals (NASDAQ:LGND) Updates FY 2023 Earnings Guidance modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.